We now have Quarter 4 H1B visa FY 2023 data and Quarter 4 PERM visa FY 2023 data and Quarter 4 H2A visa FY 2023 data.
Employer Search tool is moved to it's own page: "H1B Visa Data Search Tool"

In-Vitro Diagnostic Substance Manufacturing (NAICS code 325413) has an average growth rate of 0.07% as an H1B industry with 379 employees hired as of 2025


Top In-Vitro Diagnostic Substance Manufacturing Employers

Company Employees Average Wage
Springworks Therapeutics Operating Company 3 $136,129
Tangen Biosciences, Inc. 3 $99,160
Teco Diagnostics 3 $77,522
Alere, Inc. 2 $157,518
Amt Scientific, Llc 2 $84,760
Ansh Labs Llc 2 $67,476
Atantares Corp 2 $98,842
Azer Scientific, Inc. 2 $54,330
Biogenex Laboratories Inc. 2 $83,585
Calbiotech Inc 2 $47,185


Top In-Vitro Diagnostic Substance Manufacturing Jobs

Employees Over Time vs Average Salary Over Time

The In-vitro Diagnostic Substance Manufacturing industry has been in the H1B Visa program since 2011 where 6 employees were hired. They peaked in 2023 with 42 employees, and have since been on a decline with the most recent number of employees being 14 in 2025.
The In-vitro Diagnostic Substance Manufacturing industry has been in the H1B Visa program since 2011 where the average salary was $49,299. The industry peaked in 2024 with an average salary of $102,374, and has since been on a decline with the most recent average salary being $100,448 in 2025.